drugset / Trial / NCT02479204
Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441
RandomizedParallel-groupOpen-labelOther
Summary
The aim of the study is to investigate the safety of the concomitant administration of ACT-334441 with cardiovascular drugs.
Timeline
- Start
- 2015-04-28
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
Outcome
Outcome not reported
Stopped: “Based on results from the pilot phase, the study is terminated. No safety events leading to discontinuation were reported”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atenolol | Other / unclassified | 50 mg | — |
| Subject | Cenerimod | Small molecule | 2 mg | — |
| Subject | Cenerimod | Small molecule | 4 mg | — |
| Subject | Diltiazem | Small molecule | 240 mg | — |
Indications
No indication recorded.